Table 1 Baseline characteristics of the study patients
Total | CV events (+) | CV events (−) | P-value | |
---|---|---|---|---|
Number | 161 | 15 | 146 | — |
Age (year) | 63.5±9.2 | 68.4±6.4 | 63.0±9.3 | 0.036 |
Gender, male | 82 (51%) | 10 (67%) | 72 (49%) | 0.202 |
Body mass index (kg m−2) | 23.9±3.6 | 22.3±2.8 | 24.1±3.6 | 0.073 |
Systolic blood pressure (mm Hg) | 130.8±20.1 | 138.0±28.7 | 130.1±19.1 | 0.144 |
Diastolic blood pressure (mm Hg) | 76.7±12.0 | 77.6±13.3 | 76.6±11.9 | 0.775 |
Heart rate (beat per minute) | 69.1±10.8 | 67.1±10.4 | 69.3±10.8 | 0.504 |
eGFR (ml min−1 per 1.73 m2) | 72.9±18.7 | 56.4±20.2 | 74.6±17.7 | 0.002 |
Proteinuria (yes=1, no=0) | 15 (9%) | 4 (27%) | 11 (8%) | 0.016 |
Hemoglobin (g dl−1) | 13.4±1.6 | 12.9±2.3 | 13.4±1.5 | 0.300 |
Serum albumin (g dl−1) | 4.0±0.3 | 3.7±0.4 | 4.0±0.3 | 0.006 |
GNRI | 100.4±6.0 | 95.1±8.2 | 100.9±5.5 | 0.004 |
Hypertension | 109 (68%) | 13 (87%) | 96 (66%) | 0.100 |
Diabetes | 39 (24%) | 4 (27%) | 35 (24%) | 0.817 |
Dyslipidemia | 72 (45%) | 9 (60%) | 63 (43%) | 0.213 |
Antihypertensive agents | ||||
Angiotensin II receptor blockers | 66 (41%) | 10 (67%) | 56 (38%) | 0.034 |
Angiotensin-converting enzyme inhibitors | 18 (11%) | 4 (27%) | 14 (10%) | 0.046 |
Calcium channel blockers | 69 (43%) | 7 (47%) | 62 (42%) | 0.755 |
β-Blockers | 44 (27%) | 6 (40%) | 38 (26%) | 0.249 |
Diuretics | 24 (15%) | 8 (53%) | 16 (11%) | <0.001 |
Statins | 60 (37%) | 9 (60%) | 51 (35%) | 0.057 |
Echocardiographic parameters | ||||
LV end-diastolic diameter (mm) | 47.9±5.0 | 49.3±6.8 | 47.7±4.8 | 0.482 |
LV end-systolic diameter (mm) | 29.3±5.5 | 30.5±7.2 | 29.2±5.3 | 0.900 |
Interventricular septum thickness (mm) | 9.8±1.9 | 11.5±2.8 | 9.6±1.7 | 0.005 |
Posterior wall thickness (mm) | 9.0±1.4 | 9.9±1.7 | 8.9±1.3 | 0.027 |
LAD (mm) | 38.0±5.5 | 41.3±5.6 | 37.7±5.4 | 0.001 |
LV ejection fraction (%) | 71.1±7.3 | 69.5±9.6 | 71.2±7.0 | 0.516 |
E/e′ | 6.5±3.2 | 8.5±5.3 | 6.3±2.9 | 0.206 |
e′ (cm s−1) | 10.4±5.0 | 8.4±4.4 | 10.6±5.0 | 0.039 |
LVMI (g m−2) | 113.9±32.6 | 147.4±43.7 | 110.5±29.3 | 0.001 |